Amylin analog / Unit conversion

Cagrilintide reconstitution calculator

Enter your Cagrilintide vial size, the volume of liquid added and the dose to calculate concentration and syringe units.

Your inputs determine the result. This calculator does not recommend dosages.

Live readout

Set your draw.

Enter your vial strength, diluent, and dose to see the draw.

Mode
Resulting concentration -- mg/mL
Doses per vial --
Syringe

Conversion follows standard mg, mL, and U-100 syringe references.

Performs unit conversions only. Not medical advice. Consult your healthcare provider.

Save preset

After saving, open Presets at the top of the calculator to recall this setup.

Saved presets

No saved presets

Save a conversion from the calculator to recall it later.

    Units chart

    Cagrilintide units chart (mg to U-100 units)

    Cagrilintide units chart: mg to U-100 units

    Cagrilintide's PinPoint entry uses a 5 mg example vial size (input); no source is cited for that size. The conversion rows below are fractions of that vial, expressed in mg.

    Vial concentration

    Water mL is treated as final solution mL in these columns.

    Cagrilintide: concentration in mg per mL
    Vial contents1 mL water2 mL water3 mL water
    5 mg5 mg/mL20 U-100 units per mg2.5 mg/mL40 U-100 units per mg1.6667 mg/mL60 U-100 units per mg

    Example vial size (input): 5 mg. No source is cited for this size; it is an arithmetic input, not a sourced fact.

    Amount to units

    Example amounts (arithmetic only, not doses).

    Cagrilintide: amount to U-100 syringe units
    Amount (mg)5 mg + 1 mL5 mg + 2 mL5 mg + 3 mL
    0.1 mg2 units4 units6 units
    0.25 mg5 units10 units15 units
    0.5 mg10 units20 units30 units
    1 mg20 units40 units60 units
    2.5 mg50 units100 units150 unitsover one syringe

    Cited amounts

    This chart shows no human dose figure for Cagrilintide. The amount table contains arithmetic examples only.

    How to read this chart

    units = amount ÷ (vial mg ÷ water mL) × 100

    The reconstitution calculator walks through each step, and units to mg converts between mg, mcg, mL and units.

    The example ladder

    No preset dose values are stored for this entry, so the amount table works directly from the 5 mg example vial (input). Its rows are 0.1, 0.25, 0.5, 1, and 2.5 mg. These correspond to one fiftieth, one twentieth, one tenth, one fifth, and one half of 5 mg. This sequence lets a reader compare the same fraction across different liquid volumes.

    A 5 mg example vial in the table

    Cagrilintide's example vial size (input) is 5 mg. At a final volume of 2 mL, that amount gives a concentration of 2.5 mg per mL. The 1 mg example occupies two fifths of a milliliter, or 40 U-100 units. Moving to the 1 mL column halves that volume to 0.2 mL; moving to 3 mL raises it to 0.6 mL. The row remains a 1 mg amount through all three comparisons.

    Compound profile

    Cagrilintide at a glance

    Cagrilintide is an investigational long-acting amylin analog studied in people with overweight or obesity.[1]

    Regulatory status
    Investigational. No FDA-approved medicine contains cagrilintide (Drugs@FDA, checked 19 November 2026).[2]
    Half-life
    159 to 195 hours, measured for cagrilintide given once weekly with semaglutide 2.4 mg in the cited study.[1]
    Route
    Subcutaneous, the route used in the cited study.[1]
    Category
    Amylin analog
    Vial size
    5 mg, example vial size (input)

    Evidence

    What the research says

    The cited phase 1b publication studied cagrilintide together with subcutaneous semaglutide in adults with overweight or obesity. Ninety-five participants received treatment. The controlled, ascending-dose design examined the combination over 20 weeks, including a period of escalation followed by exposure at the assigned study level.[1]

    Researchers measured adverse events, plasma exposure, peak concentration, half-life, and exploratory changes in body weight and glycemic measures. Cagrilintide half-life ranged from 159 to 195 hours, with median peak times between 24 and 72 hours.[1]

    Because semaglutide was part of the study regimen, the reported body-weight findings are combination results. They do not isolate every effect of cagrilintide alone. The paper also distinguishes its pharmacokinetic measurements from exploratory metabolic outcomes, a useful boundary when interpreting a long-acting amylin analog.[1]

    Timing

    Half-life and timing

    159 to 195 hours, measured for cagrilintide given once weekly with semaglutide 2.4 mg in the cited study.[1]

    Calculator details

    About this calculation.

    Does a cagrilintide guide describe a GLP-1 molecule?

    The compound description identifies a long-acting amylin analog. Its position in the library's metabolic category is a navigation choice. The stored timing estimate comes from cagrilintide measured alongside semaglutide; the 5 mg example vial is an input, not a sourced product.[1]

    Does the cagrilintide calculator establish a combination ratio?

    No additional molecule appears in this entry's example vial or conversion example. A 5 mg cagrilintide listing is not the composition of an unspecified combined product. A combination would need its own independently known quantities and source context.

    What concentration is Cagrilintide at 5 mg in 1 mL?

    5 mg divided by 1 mL is 5 mg per mL. That volume spans 100 U-100 syringe units.

    How does 2 mL change the concentration of this Cagrilintide vial?

    5 mg divided by 2 mL is 2.5 mg per mL, half the concentration in the 1 mL column.

    What does the 3 mL column mean for Cagrilintide?

    5 mg divided by 3 mL is approximately 1.6667 mg per mL. The full 3 mL volume corresponds to 300 U-100 units.

    How many units is 0.5 mg of Cagrilintide from this vial in 2 mL?

    0.5 mg divided by 2.5 mg per mL is 0.2 mL, or 20 U-100 units.

    References

    Sources

    Sources checked against the cited documents on 19 November 2026.

    1. PubMed pharmacology reference 33894838Identity and research summary checked against this document on 5 October 2026. PubMed abstract, retrieved through NCBI EFetch.Retrieved 2026-10-05 · library-reference
    2. Drugs@FDA (openFDA), search for cagrilintideNo matches found (dataset last updated 18 November 2026).Retrieved 2026-11-19 · regulator
    3. PinPoint App Store descriptionFeature wording from the approved application description, not pricing.Retrieved 2026-10-05 · app-description

    Keep your protocol together

    Track the result in the app.

    Set up vials, log doses and sites, and see your next reminder in PinPoint for iOS.

    Download on the App Store
    Syringe readout: 10 units is 0.10 mL on a U-100 insulin syringe
    THE ARITHMETIC / 0.10 mL = 10 UNITS

    Keep exploring

    More tools

    PinPoint app icon

    Your next chapter starts here

    Start Day 1 with
    your numbers in place.

    Your doses, your schedule, your picture. Bring it together in PinPoint.

    Built for iPhone.

    Subscription through the App Store, cancel anytime in your Apple ID settings.